Search for: "Par Pharmaceutical, Inc." Results 121 - 140 of 171
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
26 Sep 2010, 8:41 pm by Patent Docs
Par Pharmaceutical Companies, Inc. et al. 1:10-cv-07310; filed September 22, 2010 in the Southern District of New York • Plaintiff: Biovail Laboratories International SRL • Defendants: Par Pharmaceutical Companies, Inc.; Par Pharmaceuticals, Inc. [read post]
27 Aug 2010, 2:41 pm by Bexis
Ortho Pharmaceutical Corp., 209 Cal. [read post]
7 Jun 2010, 9:59 pm by Patent Docs
Par Pharmaceutical, Inc., the Federal Circuit exercised its prerogative to illustrate its fractured jurisprudence on two issues, obviousness and inequitable conduct, in a (fortunately) nonprecedential decision. [read post]
12 May 2010, 5:49 pm by Randall Reese
The members of the Creditors' Committee are: Par Pharmaceutical, Inc. [read post]
25 Feb 2010, 11:18 am by Beck, et al.
That’s par for the course with this kind of thing. [read post]
2 Dec 2009, 11:05 am by dbmadmin
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
18 Oct 2009, 5:42 pm
  Judge Brown found that the patent in question, US Patent No. 5,565,473, was valid and enforceable, and [...]...FTC Sues Regarding AndroGel Patent Settlement The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to… [read post]
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
7 Oct 2009, 9:59 pm
Sanofi originally filed suit against Sun, Sandoz, Actavis Inc., and Par Pharmaceutical Inc., among other generic manufacturers, in June 2007, accusing them of infringing Sanofi's patent covering Eloxatin ®, U.S. [read post]
15 Sep 2009, 9:55 pm
By Suresh Pillai -- Purdue Files Appeal in Ultram ® Suit against Par Purdue Pharma Products Inc. has filed an appeal with the U.S. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs)   Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: []   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]